Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$14.28 - $19.53 $455,075 - $622,382
-31,868 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$12.99 - $20.47 $413,965 - $652,337
31,868 New
31,868 $473,000
Q2 2020

Aug 12, 2020

SELL
$46.7 - $92.04 $124,315 - $245,010
-2,662 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$48.35 - $118.68 $39,695 - $97,436
821 Added 44.6%
2,662 $168,000
Q4 2019

Jan 24, 2020

SELL
$57.36 - $124.1 $75,026 - $162,322
-1,308 Reduced 41.54%
1,841 $228,000
Q3 2019

Nov 13, 2019

BUY
$58.69 - $80.46 $184,814 - $253,368
3,149 New
3,149 $209,000
Q1 2018

Apr 13, 2018

SELL
$52.72 - $67.25 $48,344 - $61,668
-917 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$58.2 - $72.76 $53,369 - $66,720
917
917 $54,000

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.